What is the recommended method and timing for norovirus testing, and in which patients is testing indicated?

Norovirus Testing: Recommended Methods, Timing, and Indications

RT-PCR (reverse transcription-polymerase chain reaction) is the gold-standard diagnostic method for norovirus detection and should be performed on whole stool specimens collected within 48–72 hours of symptom onset, primarily in outbreak settings or when diarrhea persists beyond 7 days in immunocompromised, hospitalized, or severely dehydrated patients. 1, 2

Testing Indications

Norovirus testing is primarily indicated for outbreak investigation and infection control purposes rather than routine sporadic gastroenteritis, as no specific antiviral therapy exists. 2

Clinical Triggers for Testing:

• Outbreak settings: When two or more persons develop acute gastroenteritis in an epidemiologically linked cluster 1
• Diarrhea duration >7 days in any patient 2
• Immunocompromised patients with gastroenteritis (who may shed virus for extended periods) 2
• Hospitalized patients requiring infection control measures 2
• Severe dehydration requiring IV fluid therapy 2
• Healthcare workers, food handlers, or teachers with recent gastroenteritis due to transmission risk 3

When Testing is NOT Routinely Recommended:

• Acute diarrhea <7 days in healthy, immunocompetent individuals 2
• Sporadic cases of gastroenteritis in outpatient settings where diagnosis would not alter management 1

Recommended Testing Methods

RT-PCR (Gold Standard):

RT-PCR is the only recommended method for definitive norovirus diagnosis due to superior sensitivity and specificity. 1, 4

• Sensitivity and specificity approach 100% when performed correctly 4
• Can detect virus even after prolonged storage (≥5 years at -20°C or -70°C) 1
• Required for confirmation in all outbreak investigations 1

Enzyme Immunoassays (EIA):

EIA kits are NOT recommended for clinical diagnosis due to poor sensitivity (36-80%) despite acceptable specificity (47-100%). 1

• May be used for preliminary screening only in outbreak settings when EIA has >85% specificity and >50% sensitivity 1
• All negative EIA results must be confirmed by RT-PCR 1
• The FDA-cleared RIDASCREEN Norovirus 3rd Generation EIA may be used for preliminary outbreak identification only 1

Optimal Specimen Collection Timing

Acute Phase (Preferred):

Collect whole stool specimens within 48–72 hours of symptom onset when viral shedding peaks and stools remain liquid or semisolid. 1, 2

• This window provides maximum diagnostic sensitivity 1, 2
• Testing should begin immediately without waiting for bacterial/parasitic test results 1

Extended Window:

Specimens collected 7–10 days after onset may still yield positive results but with reduced sensitivity. 1, 2

• Useful for confirming infection in source cases (e.g., food handlers with recent diarrhea) 1
• Discuss utility with laboratory personnel before late testing 1

Specimen Collection Requirements

Type and Quantity:

• Whole stool specimens are strongly preferred over rectal swabs due to higher viral load 1
• Collect 10–50 mL bulk stool in a stool cup or urine container 1
• Rectal swabs are generally insufficient, though one study found 97.3% sensitivity when stool unavailable 5
• Vomitus may also be tested using RT-PCR, though sensitivity is unknown 1

Number of Specimens in Outbreaks:

• Collect specimens from at least 5 ill persons for outbreak confirmation 1
• Increase to 6 specimens if using EIA to achieve >90% outbreak detection sensitivity 1
• Increase specimen numbers if collecting after acute phase or in large/protracted outbreaks 1

Storage and Transport:

• Refrigerate at 4°C (39°F) if testing within 2–3 weeks 1
• Freeze at -20°C (-4°F) or -70°C (-94°F) if testing >3 weeks or for archiving 1
• Transport on ice or frozen refrigerant packs in sealed, waterproof containers 1
• Each specimen must include dates of symptom onset and collection 1

Laboratory Confirmation Criteria

An outbreak is laboratory-confirmed as norovirus when stool or vomitus from ≥2 ill persons test positive by RT-PCR, EIA, or electron microscopy. 1

Critical Pitfalls and Caveats

Prolonged Viral Shedding:

• Average shedding persists ~4 weeks after clinical recovery, with peak at 2–5 days post-onset 2
• Immunocompromised patients may shed high viral loads indefinitely; maintain isolation as long as testing remains positive 2
• Up to 30% of infections are asymptomatic but individuals still shed virus at lower titers, complicating interpretation in exposed but symptom-free contacts 2

Co-infections:

• In 64% of norovirus outbreaks, Clostridium difficile toxin tests were also positive 6
• Co-infection with adenovirus and C. difficile may confound symptom attribution, particularly in immunocompromised children 7
• Consider testing for multiple pathogens when clinical picture is atypical 8

Clinical Impact Limitations:

• Testing primarily serves infection control and epidemiologic purposes, not individual patient management, since no antiviral therapy exists 2
• In immunocompetent children, norovirus shows strong association with diarrhea, but in immunocompromised patients this association weakens due to high co-infection rates 7

Timing Impact on Outbreak Control:

• Outbreaks have lower case numbers when RT-PCR results are available before outbreak onset (P=0.028) 6
• Delays while awaiting bacterial testing can preclude viral diagnosis and prolong outbreaks 1